Yili Chuannig Biotechnology Co (SZSE:301301) EBIT per Share : ¥0.63 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co EBIT per Share?

Yili Chuannig Biotechnology Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.63.

During the past 12 months, the average EBIT per Share Growth Rate of Yili Chuannig Biotechnology Co was 44.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was 35.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Yili Chuannig Biotechnology Co's EBIT per Share or its related term are showing as below:

SZSE:301301' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 35.6 Med: 35.6 Max: 35.6
Current: 35.6

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Yili Chuannig Biotechnology Co was 35.60% per year. The lowest was 35.60% per year. And the median was 35.60% per year.

SZSE:301301's 3-Year EBIT Growth Rate is ranked better than
85.52% of 1305 companies
in the Biotechnology industry
Industry Median: 3.4 vs SZSE:301301: 35.60

Yili Chuannig Biotechnology Co's EBIT for the three months ended in Mar. 2024 was ¥437 Mil.

Yili Chuannig Biotechnology Co EBIT per Share Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co EBIT per Share Chart

Yili Chuannig Biotechnology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.71

0.55

0.32

0.54

Yili Chuannig Biotechnology Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial											0.11	0.13	0.14	0.16	0.20

Yili Chuannig Biotechnology Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Yili Chuannig Biotechnology Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1205.49	/	2239.438
=	0.54

Yili Chuannig Biotechnology Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	437.347	/	2203.843
=	0.20

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.63

Yili Chuannig Biotechnology Co (SZSE:301301) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Yili Chuannig Biotechnology Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000

Website

http://www.klcnsw.com

Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines